More on Quidel (QDEL): Q4 easily beats both EPS and revenue estimates as total sales rise over...


More on Quidel (QDEL): Q4 easily beats both EPS and revenue estimates as total sales rise over 40% Y/Y, driven largely by growth of infectious disease products due to the onset of an early and severe flu and respiratory disease season.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs